{
  "docId": "019dd923-5ca1-7489-b636-bc879d1b6d64",
  "docSlug": "17680cec2cbd3510",
  "documentTitle": "Accelerated Access Review UK Mapping",
  "authorId": "Deloitte",
  "authorName": "Deloitte",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 2,
  "pageCount": 109,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "disclaimer",
  "function": "front_matter",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "This is a formal preface/disclaimer slide for a consulting report.",
  "elementsJson": [
    "paragraph",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b636-bc879d1b6d64/2",
  "deckHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.145,
        "w": 0.904,
        "x": 0.048,
        "y": 0.585
      },
      "kind": "list",
      "text": "The NHS Five Year Forward View that committed to exploring new mechanisms for achieving quicker adoption of cost-effective innovation through partnerships, including with patients and voluntary sector organisations; The EU's Innovative Medicines Initiative to increase the speed of development of better and safer medicine through Europe's largest public-private partnership; The NHS Commissioning through Evaluation programme to examine real world clinical evidence in the absence of full trial data (e.g., expansion of the indication for use of stereotactic ablative radiotherapy beyond non-small cell lung cancer);",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c426fad7-b1d5-4901-a133-1ee49320a019",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.904,
        "x": 0.048,
        "y": 0.751
      },
      "kind": "paragraph",
      "text": "This document raises a series of interim questions regarding how best to improve NHS patient access to innovation, which will be addressed in much greater detail in the next phase of the Accelerated Access – Innovative Medicines and Medical Technologies Review. The next stage of the review will consult, review and recommend policies aimed at improving access.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c6be264-7a42-4cc1-8be0-909238cce016",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.115,
        "w": 0.904,
        "x": 0.048,
        "y": 0.306
      },
      "kind": "paragraph",
      "text": "We used extensive interviews, desk research and stakeholder workshops to build up our analysis of the pathways as they stand today and identify the perceived barriers to rapid adoption of innovation in the UK. As such this document is a single ‘snap-shot’ of how health economy participants view the current environment and may not reflect all the initiatives currently in place to address these barriers and challenges, either because the stakeholders we spoke with are not yet seeing results or because they are not aware of these programmes.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b6b8e86-b626-45bc-9c2b-7d1c54539431",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.048,
        "y": 0.905
      },
      "kind": "paragraph",
      "text": "Monitor Deloitte, CASMI and King’s Fund",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "939f1d92-3d2a-40b4-9309-9968f7d63419",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.175,
        "w": 0.904,
        "x": 0.048,
        "y": 0.113
      },
      "kind": "paragraph",
      "text": "This report presents the work undertaken in Workstream 1 of the Accelerated Access – Innovative Medicines and Medical Technologies Review during March 2015. For this workstream the consortium of Monitor Deloitte, CASMI and King’s Fund focused on describing the end-to-end ‘pathways’ for pharma, medtech and in vitro diagnostics by which innovative medical technologies pass from conception to widespread patient access, identifying key barriers to rapid NHS adoption of such innovations, challenges to Industry and opportunities to improve patient access. The overarching aim of this work was to improve patients’ health outcomes and experience through faster access to efficacious medical innovations (including digital), not to expand the market for manufacturers of innovations per se or to promote innovation for its own sake.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7958259-81a8-4f7b-90ac-db45551f78d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.904,
        "x": 0.048,
        "y": 0.539
      },
      "kind": "paragraph",
      "text": "We note that many of the highlighted barriers are being addressed in whole or in part by a series of existing initiatives. The key initiatives that are not yet built into our analysis are:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad1afc37-d879-4fdf-8a80-0213f8c8d1c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.904,
        "x": 0.048,
        "y": 0.448
      },
      "kind": "paragraph",
      "text": "We interviewed a wide range of stakeholders from across the health economy, including Industry, the Public Sector, Academia and Charities. In the available time frame we were not able to focus on interviewing a significant number of frontline clinicians and this will be an important activity for the next phase of this work.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bbae9c4e-401e-4565-a149-2c9fbbb12a42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.14,
        "x": 0.048,
        "y": 0.067
      },
      "kind": "title",
      "text": "Dear Reader,",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6455b2c-9293-402a-b77b-667631fb0579",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a05b79e2-a475-46ae-b631-3f7cad286a74",
      "evidence": "The text mentions 'a wide range of stakeholders from across the health economy, including Industry, the Public Sector, Academia and Charities'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}